NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits can be filed on behalf of shareholders of RYVYL Inc. RVYLand Invivyd, Inc. IVVD. Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.

RYVYL Inc. RVYL

Collection Period: According to the public offer of January 29, 2021 and/or January 29, 2021 to January 20, 2023

Lead Plaintiff Deadline: April 3, 2023

According to the complaint, the registration statement was false and/or misleading and/or failed to disclose that: (1) the company would restate certain financial information; (2) the company’s internal controls were inadequate; (3) the company has downplayed and concealed its internal control problems; and (4) as a result, the Registration Statement was materially incorrect and/or misleading at all relevant times.

For more information on the RYVYL class action go to: https://bespc.com/cases/RVYL

Invivyd, Inc. IVVD

Class period: November 29, 2021 – December 14, 2021

Lead Plaintiff Deadline: April 3, 2023

The Complaint alleges that during the Class Period, the Defendants failed to disclose: (1) The published epitope mappings, structural studies, and sequence analysis that the Defendants used to claim that ADG20 was active against the Omicron variant, have been inadequate, unreliable and inadequate in making claims to Omicron about the effectiveness of ADG20; (2) that defendants’ claims to Omicron regarding the efficacy of ADG20 lacked reasonable factual basis; and (3) ADG20 was over 300-fold less potent against the Omicron variant compared to its potency against earlier variants.

For more information on the Invivyd Class Action, visit: https://bespc.com/cases/IVVD

About Bragar Eagle & Squire, PC:

Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York, California and South…